Announcements Trials

Browse Landscape

Phase

Phase NA 16 Phase 4 3 Phase 2 2 Phase 1 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4 Thoracic 2 Gastrointestinal 2 Sarcoma 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Interventions

Dacarbazine 27 Nivolumab 26 pembrolizumab 22 Ipilimumab 20 3-ingenyl angelate 11 Interferon-alpha 10 Imiquimod 10 Temozolomide 9 trametinib 8 Vemurafenib 8 Photochemotherapy 8 Aminolevulinic Acid 8 methyl 5-aminolevulinate 7 dabrafenib 7 cemiplimab 7 aldesleukin 7 Introns 7 Surgical Procedures, Operative 6 Radiotherapy 6 Interferon alpha-2 6 Fluorouracil 6 Paclitaxel 5 Melphalan 5 Interleukin-2 5 Cisplatin 5 Chemotherapy, Adjuvant 5 talimogene laherparepvec 4 binimetinib 4 Specimen Handling 4 Opdualag 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Blood Specimen Collection × Dermatologic × Clear all

NCT02278887 2025-03-10

TIL

The Netherlands Cancer Institute

Phase 3 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡